Ribomic Inc.
↗Tokyo, Japan
Ribomic Inc. is a clinical-stage biopharmaceutical company based in Tokyo, Japan, specializing in the discovery and development of nucleic acid-based aptamer therapeutics. The company utilizes its proprietary RiboART (Ribomic Aptamer Refined Therapeutics) platform to generate first-in-class aptamers for a wide range of therapeutic targets, focusing on unmet medical needs in areas such as rare diseases and ophthalmology.
The company operates through both self-discovery and co-discovery business models, frequently partnering with major pharmaceutical companies to advance its pipeline. Its lead candidate, umedaptanib pegol (RBM-007), is an anti-FGF2 aptamer currently in clinical development for conditions including achondroplasia and wet age-related macular degeneration (wet AMD).
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Oligonucleotide Therapeutics
SIZE & FINANCIALS
Employees:1-50
Founded:2003
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$4.12M
STOCK
Exchange:Tokyo Stock Exchange
Ticker:4591
Market Cap:$0.03B
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2
Modalities:RNA aptamer
Active Trials:4
Trial Phases:Phase 1: 1 | Phase 2: 3
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:RIBOMIC USA Inc.
Key Partnerships:Otsuka Pharmaceutical, Astellas Pharma, Taisho Pharmaceutical, Ajinomoto Co., Inc., ASKA Pharmaceutical, Aju Pharm
COMPETITION
Position:Emerging
Competitors:MiNA Therapeutics, Orna Therapeutics, Stoke Therapeutics
LEADERSHIP
Key Executives:
Yoshikazu Nakamura - President and CEO
Hisato Oiwa - CFO / Head of Management Headquarters
Scientific Founders:Yoshikazu Nakamura
Board Members:Toshiaki Nishihata, Senya Matsufuji, Toshinobu Fujiwara
LINKS
Website:ribomic.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ribomic Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ribomic Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.